MA49885A - Composés macrocycliques - Google Patents

Composés macrocycliques

Info

Publication number
MA49885A
MA49885A MA049885A MA49885A MA49885A MA 49885 A MA49885 A MA 49885A MA 049885 A MA049885 A MA 049885A MA 49885 A MA49885 A MA 49885A MA 49885 A MA49885 A MA 49885A
Authority
MA
Morocco
Prior art keywords
macrocyclic compounds
macrocyclic
compounds
Prior art date
Application number
MA049885A
Other languages
English (en)
Inventor
Andrew Michael Chapman
Anthony Davis
Johnathan Vincent Matlock
Michael Glen Orchard
Michael Roger Tomsett
Robert Tromans
Miriam Ruth Wilson
Original Assignee
Ziylo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1704125.2A external-priority patent/GB201704125D0/en
Priority claimed from GBGB1715210.9A external-priority patent/GB201715210D0/en
Application filed by Ziylo Ltd filed Critical Ziylo Ltd
Publication of MA49885A publication Critical patent/MA49885A/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0097—Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
MA049885A 2017-03-15 2018-03-15 Composés macrocycliques MA49885A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1704125.2A GB201704125D0 (en) 2017-03-15 2017-03-15 Macrocyclic Compounds
GBGB1715210.9A GB201715210D0 (en) 2017-09-20 2017-09-20 Macrocyclic compounds

Publications (1)

Publication Number Publication Date
MA49885A true MA49885A (fr) 2020-06-24

Family

ID=61802228

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049885A MA49885A (fr) 2017-03-15 2018-03-15 Composés macrocycliques

Country Status (6)

Country Link
US (3) US10800747B2 (fr)
EP (1) EP3596055A1 (fr)
JP (2) JP7427449B2 (fr)
CN (2) CN118084813A (fr)
MA (1) MA49885A (fr)
WO (1) WO2018167503A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118084813A (zh) * 2017-03-15 2024-05-28 诺和诺德牛津研究中心有限公司 大环化合物
EP3852873A1 (fr) * 2018-09-19 2021-07-28 Ziylo Ltd Insulines sensibles au glucose et leurs utilisations
GB202201000D0 (en) 2022-01-26 2022-03-09 Carbometrics Ltd Saccharide sensing systems
WO2023144240A1 (fr) 2022-01-26 2023-08-03 Novo Nordisk Research Centre Oxford Limited Dérivés d'insuline sensibles au glucose et leurs utilisations
CN119613418B (zh) * 2024-12-09 2025-10-24 北京理工大学 一种十二脲笼型分子、制备方法及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2903077B2 (ja) * 1990-09-11 1999-06-07 科学技術振興事業団 尿素誘導体及び尿素誘導体含有組成物並びに機能薄膜
US5180481A (en) * 1992-03-24 1993-01-19 Clifton Carey Phosphate selective composition and electrode
NL1008789C2 (nl) * 1998-04-02 1999-10-05 Stichting Tech Wetenschapp Anion-complexerende verbinding, werkwijze voor de bereiding ervan, een ionselectief membraan alsmede een sensor voorzien van een dergelijke verbinding of membraan.
WO1999061583A2 (fr) * 1998-05-28 1999-12-02 Incara Pharmaceuticals Corp. Composes d'echafaudage a base d'hydrate de carbone, banques combinees, et leurs procedes de construction
GB0028964D0 (en) * 2000-11-28 2001-01-10 Smithkline Beecham Spa Novel compounds
CN1842524A (zh) * 2003-08-25 2006-10-04 先灵公司 作为选择性黑素浓集素受体拮抗剂用于治疗肥胖症及有关病症的2－取代的苯并咪唑衍生物
GB201207392D0 (en) * 2012-04-27 2012-06-13 Univ Bristol Novel compounds
CN105899211A (zh) * 2013-10-18 2016-08-24 小路弘行 使用cbp/连环蛋白的抑制剂治疗肝纤维化
PL3114128T3 (pl) 2014-03-07 2019-06-28 F. Hoffmann-La Roche Ag Nowe skondensowane w pozycji 6 heteroarylodihydropirymidyny stosowane w leczeniu i profilaktyce zakażenia wirusem zapalenia wątroby typu B
CN118084813A (zh) * 2017-03-15 2024-05-28 诺和诺德牛津研究中心有限公司 大环化合物

Also Published As

Publication number Publication date
JP2024036398A (ja) 2024-03-15
US20200399232A1 (en) 2020-12-24
CN110691777B (zh) 2024-03-01
WO2018167503A1 (fr) 2018-09-20
JP7781921B2 (ja) 2025-12-08
CN110691777A (zh) 2020-01-14
JP7427449B2 (ja) 2024-02-05
JP2020511533A (ja) 2020-04-16
US20200017454A1 (en) 2020-01-16
US10800747B2 (en) 2020-10-13
EP3596055A1 (fr) 2020-01-22
US20230365514A1 (en) 2023-11-16
CN118084813A (zh) 2024-05-28

Similar Documents

Publication Publication Date Title
EP3720430A4 (fr) Composés benzocarbonyle
EP3691623A4 (fr) Composés de benzosulfonyle
IL272249A (en) Organic compounds
EP3474845A4 (fr) Composés immunomodulateurs
MA42293A (fr) Composés antibactériens
EP3523306A4 (fr) Composés spirocycliques
MA44020A (fr) Composés antitumoraux
ME03419B (fr) Composés dihydroisoquinolinone substitués
EP3609871A4 (fr) Composés d'amide aryl cyclopropyl-amino-isoquinolinyl
DK3612519T3 (da) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser
MA50504A (fr) Composés antibactériens
EP3924358A4 (fr) Composés macrocycliques
EP3728289A4 (fr) Composés optimisés
EP3464336A4 (fr) Composés
EP3654852A4 (fr) Garrot
MA49621A (fr) Composés bifonctionnels
PT3728208T (pt) Polimorfos
EP3713941A4 (fr) Composés de pyrazolopyridinone
MA51221A (fr) Composés de pyrazolopyridinone
MA49522A (fr) Nouveaux composés de quinoléinone
MA48946A (fr) Composés
HUE056928T2 (hu) Új vegyületek
DK3672941T3 (da) Pyridylpyridonforbindelser
MA42034A (fr) Composés pipéridiniques tricycliques
MA49880A (fr) Composés anticancéreux